Vaden, R.M.; Oswald, N.W.; Potts, M.B.; MacMillan, J.B.; White, M.A.
FUSION-Guided Hypothesis Development Leads to the Identification of N6,N6-Dimethyladenosine, a Marine-Derived AKT Pathway Inhibitor. Mar. Drugs 2017, 15, 75.
https://doi.org/10.3390/md15030075
AMA Style
Vaden RM, Oswald NW, Potts MB, MacMillan JB, White MA.
FUSION-Guided Hypothesis Development Leads to the Identification of N6,N6-Dimethyladenosine, a Marine-Derived AKT Pathway Inhibitor. Marine Drugs. 2017; 15(3):75.
https://doi.org/10.3390/md15030075
Chicago/Turabian Style
Vaden, Rachel M., Nathaniel W. Oswald, Malia B. Potts, John B. MacMillan, and Michael A. White.
2017. "FUSION-Guided Hypothesis Development Leads to the Identification of N6,N6-Dimethyladenosine, a Marine-Derived AKT Pathway Inhibitor" Marine Drugs 15, no. 3: 75.
https://doi.org/10.3390/md15030075
APA Style
Vaden, R. M., Oswald, N. W., Potts, M. B., MacMillan, J. B., & White, M. A.
(2017). FUSION-Guided Hypothesis Development Leads to the Identification of N6,N6-Dimethyladenosine, a Marine-Derived AKT Pathway Inhibitor. Marine Drugs, 15(3), 75.
https://doi.org/10.3390/md15030075